Claude-Henry Volmar, Ph.D.
Affiliations: | 2011- | Center for Therapeutic Innovation and Department of Psychiatry | University of Miami Miller School of Medicine, Miami, FL, United States |
Area:
Drug Discovery, Neuroscience, Cancer Biology, Precision Medicine, Molecular Biology, Cell BiologyGoogle:
"Claude-Henry Volmar"Mean distance: 35622
Parents
Sign in to add mentorMichael Mullan | grad student | 2009 | The Roskamp Institute | |
Ophelia Weeks | grad student | 2009 | Florida International | |
(Relevance of CD40/CD40L downstream pathways to Alzheimer's disease.) |
Collaborators
Sign in to add collaboratorClaes Wahlestedt | collaborator | 2011- | University of Miami Miller School of Medicine |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Lalwani RC, Volmar CH, Wahlestedt C, et al. (2023) Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer's Disease. Biomedicines. 11 |
Dennison J, Mendez A, Szeto A, et al. (2023) Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD Mouse. Biomolecules. 13 |
McCartan R, Khorkova O, Volmar CH, et al. (2023) Nucleic acid-based therapeutics for the treatment of central nervous system disorders. Frontiers in Genetics. 14: 1250276 |
Khorkova O, Stahl J, Joji A, et al. (2023) Long non-coding RNA-targeting therapeutics: discovery and development update. Expert Opinion On Drug Discovery. 1-19 |
Stokes T, Cen HH, Kapranov P, et al. (2023) Transcriptomics for Clinical and Experimental Biology Research: Hang on a Seq. Advanced Genetics (Hoboken, N.J.). 4: 2200024 |
Khorkova O, Stahl J, Joji A, et al. (2023) Amplifying gene expression with RNA-targeted therapeutics. Nature Reviews. Drug Discovery |
Ricciardi NR, Modarresi F, Lohse I, et al. (2023) Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer's Disease Models. Molecular Neurobiology |
Khorkova O, Stahl J, Joji A, et al. (2022) Natural antisense transcripts as drug targets. Frontiers in Molecular Biosciences. 9: 978375 |
Dennison JL, Al-Ali H, Volmar CH, et al. (2022) Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients. Cancers. 14 |
Kemper C, Benham D, Brothers S, et al. (2022) Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL ). Aaps Open. 8: 11 |